Lataa...
The dawn of hedgehog inhibitors: Vismodegib
Cancer, one of the leading causes of death worldwide is estimated to increase to approximately 13.1 million by 2030. This has amplified the research in oncology towards the exploration of novel targets. Recently there has been lots of interest regarding the hedgehog (Hh) pathway, which plays a signi...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3643342/ https://ncbi.nlm.nih.gov/pubmed/23662017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.107628 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|